Analyzing DocGo Inc (DCGO)’s financial ratios for investment purposes

As of close of business last night, DocGo Inc’s stock clocked out at $5.80, down -1.36% from its previous closing price of $5.88. In other words, the price has decreased by -$0.08 from its previous closing price. On the day, 978595 shares were traded. DCGO stock price reached its highest trading level at $5.95 during the session, while it also had its lowest trading level at $5.78.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.



To gain a deeper understanding of DCGO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.36 and its Current Ratio is at 2.36. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $15.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 16 when Bienstock Lee sold 1,667 shares for $5.89 per share. The transaction valued at 9,819 led to the insider holds 299,037 shares of the business.

Tendler Ely D sold 10,000 shares of DCGO for $52,900 on Oct 02. The General Counsel and Secretary now owns 23,088 shares after completing the transaction at $5.29 per share. On Sep 15, another insider, Tendler Ely D, who serves as the General Counsel and Secretary of the company, sold 10,000 shares for $5.91 each. As a result, the insider received 59,100 and left with 23,088 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 602.60M and an Enterprise Value of 570.84M. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 81.81, and their Forward P/E ratio for the next fiscal year is 14.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13 while its Price-to-Book (P/B) ratio in mrq is 2.09. Its current Enterprise Value per Revenue stands at 1.26 whereas that against EBITDA is 44.74.

Stock Price History:

Over the past 52 weeks, DCGO has reached a high of $10.82, while it has fallen to a 52-week low of $4.88. The 50-Day Moving Average of the stock is 5.80, while the 200-Day Moving Average is calculated to be 8.11.

Shares Statistics:

It appears that DCGO traded 1.05M shares on average per day over the past three months and 1.17M shares per day over the past ten days. A total of 102.41M shares are outstanding, with a floating share count of 87.46M. Insiders hold about 15.79% of the company’s shares, while institutions hold 52.56% stake in the company. Shares short for DCGO as of Oct 30, 2023 were 9.9M with a Short Ratio of 9.90M, compared to 10.5M on Sep 28, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.53% and a Short% of Float of 10.93%.

Earnings Estimates

As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.11 for the current quarter, with a high estimate of $0.14 and a low estimate of $0.08, while EPS last year was $0.08. The consensus estimate for the next quarter is $0.08, with high estimates of $0.17 and low estimates of $0.02.

Analysts are recommending an EPS of between $0.27 and $0.08 for the fiscal current year, implying an average EPS of $0.14. EPS for the following year is $0.35, with 7 analysts recommending between $0.52 and $0.19.

Revenue Estimates

In the current quarter, 7 analysts expect revenue to total $190.16M. It ranges from a high estimate of $196.6M to a low estimate of $163.31M. As of the current estimate, DocGo Inc’s year-ago sales were $108.78M, an estimated increase of 74.80% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $191.13M, an increase of 71.40% less than the figure of $74.80% in the same quarter last year. There is a high estimate of $212.35M for the next quarter, whereas the lowest estimate is $169.34M.

A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $621.6M, while the lowest revenue estimate was $549.48M, resulting in an average revenue estimate of $609.63M. In the same quarter a year ago, actual revenue was $440.51M, up 38.40% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $745.23M in the next fiscal year. The high estimate is $830.6M and the low estimate is $695.99M. The average revenue growth estimate for next year is up 22.20% from the average revenue estimate for this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular